(NASDAQ: AMED) Amedisys's forecast annual revenue growth rate of 3.51% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.92%.
Amedisys's revenue in 2025 is $2,371,691,000.On average, 7 Wall Street analysts forecast AMED's revenue for 2025 to be $80,571,948,733, with the lowest AMED revenue forecast at $78,995,555,880, and the highest AMED revenue forecast at $82,265,704,611.
In 2026, AMED is forecast to generate $84,459,959,968 in revenue, with the lowest revenue forecast at $81,399,922,560 and the highest revenue forecast at $87,451,207,415.